CytoMed Therapeutics’ chairman increases effective holdings to 21.95%

* CytoMed Therapeutics (NASDAQ:GDTC [https://seekingalpha.com/symbol/GDTC]) said on Wednesday that its executive chairman and substantial shareholder, Peter Choo, has increased his shareholding [https://seekingalpha.com/pr/20275147-cytomed-therapeutics-chairman-increases-effective-holdings-to-21_95-percent] in the company through recent open-market purchases of 105,824 shares.
* This is on top of 187,500 shares, which he holds personally, bringing his personal stake in CytoMed to 2.50% as of today.
* In addition, he is also a 55% shareholder of Glorious Finance and the sole shareholder of EP Capital, representing 2.28M shares, or 19.45% of the company.
* In aggregate, he owns 2.39M shares, representing 21.95% of the company’s total outstanding shares.
* CytoMed Therapeutics (NASDAQ:GDTC [https://seekingalpha.com/symbol/GDTC]) shares were up more than 7% in premarket trading.

MORE ON CYTOMED THERAPEUTICS

* CytoMed Therapeutics Limited (GDTC) Q2 2025 Earnings Call Prepared Remarks Transcript [https://seekingalpha.com/article/4827504-cytomed-therapeutics-limited-gdtc-q2-2025-earnings-call-prepared-remarks-transcript]
* Financial information for CytoMed Therapeutics  [https://seekingalpha.com/symbol/GDTC/income-statement]